FindTrial
Sign In

Clinical study for amniotic membrane assisted vitrectomy for large macular hole

Clinical study for amniotic membrane assisted vitrectomy for large macular hole

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021256
Enrollment
Unknown
Registered
2019-02-03
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular hole

Interventions

amniotic membrane group:ILM peeling combined with biological amniotic tamping
inverted ILM flap group:inverted ILM flap
ILM peeling group:ILM peeling

Sponsors

The Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Idiopathic macular hole (hole diameter >400µm); (2) Aged at least 18 years old; (3) be able and willing to participate in clinical trials

Exclusion criteria

Exclusion criteria: (1) macular hole of high myopia (diopter >-6.0D, axial length>26mm); (2) traumatic macular hole; (3) history of vitreoretinal surgery; (4) history of intraocular temponade with gas; (5) history of laser treatment for macular hole; (6) not expected to follow in the clinical trial center; (7) those with neurological or mental diseases that cannot cooperate with the examination; (8) the informed consent cannot be obtained

Design outcomes

Primary

MeasureTime frame
Macular hole closure rate;best corrected visual acuity;—

Countries

China

Contacts

Public ContactYong Wei

The Eye Hospital of Wenzhou Medical University

weiyongdoctor@163.com+86 15057551266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026